Global Calcimimetic Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

According to our (Global Info Research) latest study, the global Calcimimetic market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.

A calcimimetic is a pharmaceutical drug that mimics the action of calcium on tissues, by allosteric activation of the calcium-sensing receptor that is expressed in various human organ tissues. Calcimimetics are used to treat secondary hyperparathyroidism (SHPT).

The parathyroid gland is an essential gland for human life, and SHPT is a common and serious decompensation disease in patients with chronic kidney disease receiving dialysis treatment, and it is one of the important manifestations of mineral metabolism disorders. According to the 2012 China Epidemiological Survey, the number of patients with middle and end-stage renal disease in China is about 2 million, the dialysis rate is less than 20%, and the conversion rate of SHPT in patients with mineral and bone metabolic disorders (CKD-MBD) is close to 50%. . The dialysis rate is 90% in developed countries (United States, Europe, Japan). Based on this, it can be predicted that in the future, the number of SHPT people will release a large growth space with the improvement of the diagnosis, detection and treatment of chronic kidney disease.

This report is a detailed and comprehensive analysis for global Calcimimetic market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Calcimimetic market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global Calcimimetic market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global Calcimimetic market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global Calcimimetic market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Calcimimetic

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Calcimimetic market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Amgen, Ono Pharmaceutical, Aurobindo Pharma, Roche Holding AG, Lilly, Merck & Co., Inc., Johnsons & Johnsons, Bristol Myers Squibb, Accord Healthcare , Inc., Alkem Labs, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Calcimimetic market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Cinacalcet
Etelcalcetide
Evocalcet

Market segment by Application
Hospital
Clinic

Major players covered
Amgen
Ono Pharmaceutical
Aurobindo Pharma
Roche Holding AG
Lilly
Merck & Co., Inc.
Johnsons & Johnsons
Bristol Myers Squibb
Accord Healthcare , Inc.
Alkem Labs
Viatris
Teva Pharmaceutical Industries Ltd

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Calcimimetic product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Calcimimetic, with price, sales quantity, revenue, and global market share of Calcimimetic from 2020 to 2025.

Chapter 3, the Calcimimetic competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Calcimimetic breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Calcimimetic market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Calcimimetic.

Chapter 14 and 15, to describe Calcimimetic sales channel, distributors, customers, research findings and conclusion.